Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 58 citing articles:

Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set
Hengrui Liu, Tao Tang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 91
Pan-cancer genetic analysis of disulfidptosis-related gene set
Hengrui Liu, Tao Tang
Cancer Genetics (2023) Vol. 278-279, pp. 91-103
Open Access | Times Cited: 69
Identification of the novel exhausted T cell CD8 + markers in breast cancer
Hengrui Liu, Angela Dong, Ayana Meegol Rasteh, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Genetic expression in cancer research: Challenges and complexity
Hengrui Liu, Zheng Guo, Panpan Wang
Gene Reports (2024), pp. 102042-102042
Closed Access | Times Cited: 30
Is the voltage-gated sodium channel β3 subunit (SCN3B) a biomarker for glioma?
Hengrui Liu, Jieling Weng, Christopher Huang, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 25
Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer
Ling Ou, Hengrui Liu, Chang Peng, et al.
Heliyon (2024) Vol. 10, Iss. 17, pp. e37046-e37046
Open Access | Times Cited: 21
Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers
Hengrui Liu, Miray Karsidag, Kunwer Chhatwal, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314745-e0314745
Open Access | Times Cited: 4
Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma
Hengrui Liu
Cancer Genetics (2023) Vol. 274-275, pp. 21-25
Open Access | Times Cited: 41
MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification
Hengrui Liu, Tao Tang
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 40
ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment
Haojie Dai, Xi Zhang, You‐Yang Zhao, et al.
Hereditas (2025) Vol. 162, Iss. 1
Open Access | Times Cited: 1
An example of toxic medicine used in Traditional Chinese Medicine for cancer treatment.
Hengrui Liu
PubMed (2023) Vol. 43, Iss. 2, pp. 209-210
Closed Access | Times Cited: 22
Identification of molecular targets of Hypericum perforatum in blood for major depressive disorder: a machine-learning pharmacological study
Zewen Xu, Ayana Meegol Rasteh, Angela Dong, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer
Chinnadurai Mani, Ganesh Acharya, Karunakar Saamarthy, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 14
Pan-Cancer Genetic Analysis of Mitochondrial DNA Repair Gene Set
Angela Dong, Ayana Meegol Rasteh, Hengrui Liu
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Descriptive pan-cancer genetic analysis of disulfidptosis-related gene set
Hengrui Liu, Tao Tang
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Closed Access | Times Cited: 13
The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy
Victor M. Matias-Barrios, Xuesen Dong
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 94-94
Open Access | Times Cited: 12
Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma
Ziyang Xu, Wenbin Jiang, Li Liu, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 4
Efficacy and safety of endovascular repair versus open surgery for ruptured abdominal aortic aneurysm: a comparative study
Mingkui Huang, Yinhe Tang
American Journal of Cancer Research (2025) Vol. 15, Iss. 3, pp. 1234-1247
Closed Access
EFTUD2 is a promising diagnostic and prognostic indicator involved in the tumor immune microenvironment and glycolysis of lung adenocarcinoma
Ankang Yin, Yufan Xu, Xiyang Su, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
RAD51 expression and prognostic impact in patients with stomach adenocarcinoma
Baiyu Jian, Hao Zhang, Fan Li, et al.
PeerJ (2025) Vol. 13, pp. e19179-e19179
Open Access
Development of a hypoxia-responsive macrophage prognostic model using single-cell and bulk RNA sequencing in pancreatic cancer
Heming Ge, Gerrit Wolters‐Eisfeld, Thilo Hackert, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0322618-e0322618
Open Access
Potential role of P4HB in the tumor microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on KIRC
L. Zhang, Yuwei Li, Tianyi Xie, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer
Jinlong Tian, Yanlei Li, Tong Yu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Icariin Induces Chondrocyte Degeneration via Activation of the NF‐κB Signalling Pathway and Reduces the Inflammation Factor Expression Induced by Lipopolysaccharide
Tianjun Zhai, Jie Wang, Yeping Chen, et al.
Immunology (2025)
Closed Access
Predictors of distant metastasis or local recurrent after radiotherapy in patients with cervical cancer
Chufan Wu, Xiaojuan Lv, Fangfang Wang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top